In many countries, automated insulin delivery systems (or hybrid closed loop systems) have become standard of care for management of T1D in children and is a tool that increases quality of life (and sleep!) of patients and parents alike. Unfortunately, accessibility to these technology remains an issue for T1D kids in Singapore. Due to the low number of patients and demand, the supply of AID systems here is not a priority for many of these companies. With telehealth, this gap is now closing, but it does not defray the high cost of such technology without sufficient subsidies or coverage by health insurances. The cost of pumps could range anywhere between $6000 – $11,000, on top of ongoing necessary consumables!

It is our hope as caregivers that more aid can be extended so patients and parents can choose what is best for their/their children’s health. Ultimately, what parents hope for (apart from a cure) for their T1D child is NORMALITY, to spend as little TIME thinking about diabetes as possible (financially and medically), and to minimise COMPLICATIONS in the long run.